IDenta Corp (IDTA)
0.50
0.00 (0.00%)
USD |
OTCM |
Nov 04, 16:00
IDenta Gross Profit Margin (Quarterly): 69.38% for June 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 69.38% |
March 31, 2024 | 79.95% |
June 30, 2023 | 61.84% |
March 31, 2023 | 72.33% |
December 31, 2022 | 89.62% |
September 30, 2022 | 73.13% |
June 30, 2022 | 64.16% |
March 31, 2022 | 53.84% |
December 31, 2021 | 91.89% |
September 30, 2021 | 58.15% |
June 30, 2021 | 70.68% |
March 31, 2021 | 73.00% |
December 31, 2020 | 51.54% |
September 30, 2020 | 75.79% |
Date | Value |
---|---|
June 30, 2020 | 40.65% |
March 31, 2020 | 79.13% |
December 31, 2019 | |
September 30, 2019 | 52.24% |
June 30, 2019 | 51.51% |
March 31, 2019 | 66.56% |
December 31, 2018 | |
September 30, 2018 | 76.55% |
June 30, 2018 | 42.71% |
March 31, 2018 | 80.86% |
December 31, 2017 | 63.55% |
September 30, 2017 | 64.53% |
June 30, 2017 | 63.21% |
March 31, 2017 | 84.17% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
40.65%
Minimum
Jun 2020
91.89%
Maximum
Dec 2021
69.07%
Average
71.50%
Median
Gross Profit Margin (Quarterly) Benchmarks
InspireMD Inc | 19.03% |
IR-Med Inc | -- |
Pluri Inc | -- |
BiomX Inc | -- |
Raphael Pharmaceutical Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | 28.44% |
Return on Assets | 9.63% |
Return on Invested Capital | 14.80% |
Profit Margin (Quarterly) | 22.13% |
Operating Margin (Quarterly) | 20.10% |
Return on Net Operating Assets | 12.71% |